Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist pretreatment versus standard GnRH antagonist IVF/ICSI protocol in poor ovarian responders
IRCT20130603013566N10Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gonadotropin-releasing hormone agonist in infertility and poor ovarian response (POR) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Number of obtained oocytes and Quality of obtained oocytes. Started Aug 2022; status: completed.
02
Drugs
gonadotropin-releasing hormone agonist
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20130603013566N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130603013566N10.